共查询到20条相似文献,搜索用时 15 毫秒
1.
Dasgupta B Cimmino MA Maradit-Kremers H Schmidt WA Schirmer M Salvarani C Bachta A Dejaco C Duftner C Jensen HS Duhaut P Poór G Kaposi NP Mandl P Balint PV Schmidt Z Iagnocco A Nannini C Cantini F Macchioni P Pipitone N Amo MD Espígol-Frigolé G Cid MC Martínez-Taboada VM Nordborg E Direskeneli H Aydin SZ Ahmed K Hazleman B Silverman B Pease C Wakefield RJ Luqmani R Abril A Michet CJ Marcus R Gonter NJ Maz M Carter RE Crowson CS Matteson EL 《Annals of the rheumatic diseases》2012,71(4):484-492
The objective of this study was to develop EULAR/ACR classification criteria for polymyalgia rheumatica (PMR). Candidate criteria were evaluated in a 6-month prospective cohort study of 125 patients with new onset PMR and 169 non-PMR comparison subjects with conditions mimicking PMR. A scoring algorithm was developed based on morning stiffness >45 minutes (2 points), hip pain/limited range of motion (1 point), absence of RF and/or ACPA (2 points), and absence of peripheral joint pain (1 point). A score ≥4 had 68% sensitivity and 78% specificity for discriminating all comparison subjects from PMR. The specificity was higher (88%) for discriminating shoulder conditions from PMR and lower (65%) for discriminating RA from PMR. Adding ultrasound, a score ≥5 had increased sensitivity to 66% and specificity to 81%. According to these provisional classification criteria, patients ≥50 years old presenting with bilateral shoulder pain, not better explained by an alternative pathology, can be classified as having PMR in the presence of morning stiffness>45 minutes, elevated CRP and/or ESR and new hip pain. These criteria are not meant for diagnostic purposes. 相似文献
2.
3.
4.
Zulian F Woo P Athreya BH Laxer RM Medsger TA Lehman TJ Cerinic MM Martini G Ravelli A Russo R Cuttica R de Oliveira SK Denton CP Cozzi F Foeldvari I Ruperto N 《Arthritis and rheumatism》2007,57(2):203-212
OBJECTIVE: To develop criteria for the classification of systemic sclerosis (SSc) in children (juvenile SSc). METHODS: The study consisted of 3 phases: 1) collection of data on the signs and symptoms of actual patients with juvenile SSc that are useful for defining involvement of a particular organ; 2) selection of the parameters essential for the classification of juvenile SSc and preparation of a set of provisional classification criteria (PCC) using 2 Delphi surveys; 3) consensus conference consisting of 2 steps: discussion and rating of clinical profiles of 160 patients with definite juvenile SSc, possible juvenile SSc, or other fibrosing diseases as "having or not having juvenile SSc," using nominal group technique, and defining those PCC with the best statistical performance and highest face validity by using the clinical profiles of patients with definite juvenile SSc as the gold standard. RESULTS: In phase 1, 55 centers submitted clinical data on 153 patients with juvenile SSc. A total of 48 signs and symptoms were derived from these patient data and were used to define 9 organ system categories (cutaneous, vascular, gastrointestinal, respiratory, renal, cardiac, neurologic, musculoskeletal, and serologic). During phase 2, these were reduced to 21 criteria (3 major criteria [Raynaud's phenomenon, proximal skin sclerosis/induration of the skin, and sclerodactyly] and 18 minor criteria) and combined to generate 86 different PCC. At the consensus conference, these 86 definitions were tested on the case profiles of 127 patients with juvenile SSc. The PCC with the highest ranking were proximal sclerosis/induration and at least 2 minor criteria. CONCLUSION: These provisional classification criteria for juvenile SSc will help standardize the conduct of clinical research, epidemiologic and outcome studies, and therapeutic trials. 相似文献
5.
Tim L. Th. A. Jansen Nicola Dalbeth Jaap Fransen H. Ralph Schumacher Dianne Berendsen Melanie Brown Hyon Choi N. Lawrence Edwards Hein J. E. M. Janssens Frédéric Lioté Raymond P. Naden George Nuki Alexis Ogdie Fernando Perez‐Ruiz Kenneth Saag Jasvinder A. Singh John S. Sundy Anne‐Kathrin Tausche Janitzia Vaquez‐Mellado Steven A. Yarows William J. Taylor 《Arthritis \u0026amp; Rheumatology》2015,67(10):2557-2568
6.
Shahouri SH Michaud K Mikuls TR Caplan L Shaver TS Anderson JD Weidensaul DN Busch RE Wang S Wolfe F 《Arthritis and rheumatism》2011,63(11):3204-3215
7.
Felson DT Smolen JS Wells G Zhang B van Tuyl LH Funovits J Aletaha D Allaart CF Bathon J Bombardieri S Brooks P Brown A Matucci-Cerinic M Choi H Combe B de Wit M Dougados M Emery P Furst D Gomez-Reino J Hawker G Keystone E Khanna D Kirwan J Kvien TK Landewé R Listing J Michaud K Martin-Mola E Montie P Pincus T Richards P Siegel JN Simon LS Sokka T Strand V Tugwell P Tyndall A van der Heijde D Verstappen S White B Wolfe F Zink A Boers M 《Annals of the rheumatic diseases》2011,70(3):404-413
8.
Daiki Nakagomi Kei Ikeda Ayako Okubo Taro Iwamoto Yoshie Sanayama Kentaro Takahashi Mieko Yamagata Hiroaki Takatori Kotaro Suzuki Katsuhiko Takabayashi Hiroshi Nakajima 《Arthritis \u0026amp; Rheumatology》2013,65(4):890-898
Objective
The 2010 American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) classification criteria for rheumatoid arthritis (RA) refer to a possible use of ultrasound “for confirmation of the clinical findings.” We undertook this study to determine the optimized definition of ultrasound‐detected synovitis for the 2010 ACR/EULAR criteria and to assess the impact of its use on the accuracy of RA classification.Methods
One hundred nine patients with musculoskeletal symptoms for ≤3 years were enrolled in the study. Patients underwent clinical, laboratory, radiographic, and comprehensive ultrasonographic assessments at baseline and received routine management from expert rheumatologists who were blinded to the ultrasound findings.Results
Sensitivity and specificity of the 2010 ACR/EULAR criteria using different definitions of synovitis to identify patients who developed a disease requiring methotrexate (MTX) treatment within 1 year were 58.5% and 79.4%, respectively, for clinical synovitis (tenderness or swelling), 78.0% and 79.4%, respectively, for ultrasound‐detected synovitis with a gray‐scale (GS) imaging score ≥1 (GS ≥1 ultrasound synovitis), and 56.1% and 93.7%, respectively, for GS ≥2 ultrasound synovitis or a synovial power Doppler (PD) signal score ≥1 (GS ≥2/PD ≥1 ultrasound synovitis). Receiver operating characteristic curve analysis for the criteria scores revealed the largest area under the curve with GS ≥2/PD ≥1 ultrasound synovitis.Conclusion
Ultrasound assessment improves the accuracy of the 2010 ACR/EULAR criteria for identifying patients with a disease requiring MTX treatment. Our data provide preliminary but vital information for the methodology to confirm the presence of synovitis using ultrasound in the 2010 ACR/EULAR criteria.9.
10.
Ohara Asami Iwata Naomi Sugiura Shiro Abe Naoki Nakaseko Haruna Kawabe Shinji 《Clinical rheumatology》2022,41(8):2483-2489
Clinical Rheumatology - This study aimed to compare the sensitivity and specificity of the European League Against Rheumatism/American College of Rheumatology-2019 (EULAR/ACR-2019) classification... 相似文献
11.
12.
Angelo Ravelli Francesca Minoia Sergio Davì AnnaCarin Horne Francesca Bovis Angela Pistorio Maurizio Aric Tadej Avcin Edward M. Behrens Fabrizio De Benedetti Lisa Filipovic Alexei A. Grom Jan‐Inge Henter Norman T. Ilowite Michael B. Jordan Raju Khubchandani Toshiyuki Kitoh Kai Lehmberg Daniel J. Lovell Paivi Miettunen Kim E. Nichols Seza Ozen Jana Pachlopnik Schmid Athimalaipet V. Ramanan Ricardo Russo Rayfel Schneider Gary Sterba Yosef Uziel Carol Wallace Carine Wouters Nico Wulffraat Erkan Demirkaya Hermine I. Brunner Alberto Martini Nicolino Ruperto Randy Q. Cron 《Arthritis \u0026amp; Rheumatology》2016,68(3):566-576
13.
van Gestel AM Anderson JJ van Riel PL Boers M Haagsma CJ Rich B Wells G Lange ML Felson DT 《The Journal of rheumatology》1999,26(3):705-711
We compared the validity of the American College of Rheumatology (ACR) and the European League of Associations for Rheumatology (EULAR) definitions of response in rheumatoid arthritis (RA) clinical trials. US: ACR and EULAR improvement criteria were calculated in 7 large randomized RA clinical trials. The discriminant validity of the response criteria between treatment groups was studied using the Mantel-Haenszel chi-squared value. To compare both sets of criteria the chi-squared ratio was determined for each trial. Europe: In 2 large randomized RA clinical trials, ACR and EULAR criteria were calculated, once with extensive and once with 28 joint counts. The classification of patients with these 4 criteria were compared with each other using cross tables. We further studied the difference in response between treatment groups per trial, the association of response with patient and investigator assessment of improvement, and the association of response with radiological progression. US: The chi-squared ratio for most trials was close to 1. There was no clear pattern suggesting that the discriminant validity of the ACR criteria was stronger than the discriminant validity of the EULAR definition of response or vice versa. Europe: Conflicting results between ACR and EULAR were present in only 3% of patients in both trials. The discriminant validity of all 4 criteria (ACR and EULAR with reduced and extensive joint counts) was comparable. All criteria were related with the overall assessment of improvement by both investigator and patient. The association with radiographic progression was comparable for EULAR and ACR improvement criteria. There is a high level of agreement between ACR and EULAR improvement classification, and their validity is equivalent. The discriminating potential of the criteria between treatment groups is comparable, as is the association with patient's and investigator's overall assessment and with radiographic progression. 相似文献
14.
2013 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Systemic Sclerosis Outperform the 1980 Criteria: Data From the Canadian Scleroderma Research Group 下载免费PDF全文
Hebah Alhajeri Marie Hudson Janet Pope Solène Tatibouet David Robinson Nader Khalidi Peter Docherty Ariel Masetto Jean‐Pierre Mathieu Sophie Ligier Tamara Grodzicky Sharon LeClercq Carter Thorne Geneviève Gyger Murray Baron 《Arthritis care & research》2015,67(4):582-587
15.
16.
17.
Routine Assessment of Patient Index Data 3 and the American College of Rheumatology/European League Against Rheumatism Provisional Remission Definitions as Predictors of Radiographic Outcome in a Rheumatoid Arthritis Clinical Trial With Tocilizumab 下载免费PDF全文
Muznay N. Khawaja Martin J. Bergman Jeffrey Yourish Jinglan Pei William Reiss Edward Keystone 《Arthritis care & research》2017,69(5):609-615
18.
Ruperto N Ravelli A Pistorio A Ferriani V Calvo I Ganser G Brunner J Dannecker G Silva CA Stanevicha V Cate RT van Suijlekom-Smit LW Voygioyka O Fischbach M Foeldvari I Hilario O Modesto C Saurenmann RK Sauvain MJ Scheibel I Sommelet D Tambic-Bukovac L Barcellona R Brik R Ehl S Jovanovic M Rovensky J Bagnasco F Lovell DJ Martini A;Paediatric Rheumatology International Trials Organisation 《Arthritis and rheumatism》2008,59(1):4-13
19.
Cañete JD Suárez B Hernández MV Sanmartí R Rego I Celis R Moll C Pinto JA Blanco FJ Lozano F 《Annals of the rheumatic diseases》2009,68(10):1547-1552
20.
Gossec L Smolen JS Gaujoux-Viala C Ash Z Marzo-Ortega H van der Heijde D FitzGerald O Aletaha D Balint P Boumpas D Braun J Breedveld FC Burmester G Cañete JD de Wit M Dagfinrud H de Vlam K Dougados M Helliwell P Kavanaugh A Kvien TK Landewé R Luger T Maccarone M McGonagle D McHugh N McInnes IB Ritchlin C Sieper J Tak PP Valesini G Vencovsky J Winthrop KL Zink A Emery P;European League Against Rheumatism 《Annals of the rheumatic diseases》2012,71(1):4-12